Arnt 2 inhibitors are a class of chemical compounds that specifically target the Arnt 2 protein, which is a member of the aryl hydrocarbon receptor nuclear translocator (ARNT) family of transcription factors. Arnt 2, also known as HIF-1β, plays a central role in regulating gene expression by forming heterodimeric complexes with other transcription factors, such as hypoxia-inducible factors (HIFs) and the aryl hydrocarbon receptor (AHR). These complexes bind to specific DNA sequences to regulate the transcription of genes involved in processes like oxygen sensing, metabolism, and environmental response. Inhibitors of Arnt 2 disrupt its ability to form these functional complexes, thereby interfering with the transcriptional regulation that relies on Arnt 2's activity. This disruption can affect various gene expression pathways, particularly those related to cellular responses to environmental and metabolic signals.
The design of Arnt 2 inhibitors focuses on small molecules that can selectively bind to functional domains of the Arnt 2 protein, particularly those involved in its dimerization with other transcription factors or its binding to DNA. By blocking these interactions, the inhibitors prevent Arnt 2 from participating in the formation of active transcriptional complexes, leading to a reduction in gene expression regulated by Arnt 2-associated pathways. Structural studies of Arnt 2 have been instrumental in identifying key regions necessary for its function, allowing researchers to design inhibitors with high specificity and minimal off-target effects. Arnt 2 inhibitors serve as valuable tools for exploring the molecular mechanisms governing transcription factor dimerization and gene regulation, offering insights into how cells respond to environmental changes. These inhibitors allow for a deeper understanding of the complex networks of transcriptional control that involve Arnt 2 and its partners in cellular processes such as hypoxia response and metabolic adaptation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
YC-1 | 170632-47-0 | sc-202856 sc-202856A sc-202856B sc-202856C | 1 mg 5 mg 10 mg 50 mg | $33.00 $124.00 $218.00 $947.00 | 9 | |
YC-1 inhibits hypoxia-inducible factor (HIF), potentially impacting ARNT2 activity in hypoxia response pathways. | ||||||
Quinomycin A | 512-64-1 | sc-202306 | 1 mg | $166.00 | 4 | |
Quinomycin A is a HIF-1 inhibitor, indirectly affecting ARNT2 by altering HIF-mediated transcription. | ||||||
N,N′-(Dithiodi-2,1-ethanediyl)bis[2,5-dichloro-benzenesulfonamide | 927822-86-4 | sc-497219 | 25 mg | $330.00 | ||
KC7F2 is a HIF-2α inhibitor, potentially modulating ARNT2 activity in hypoxia-inducible pathways. | ||||||
PX-478 | 685898-44-6 | sc-507409 | 10 mg | $175.00 | ||
PX-478 inhibits HIF-1α, potentially affecting ARNT2's role in hypoxia-responsive gene expression. | ||||||
Chetomin | 1403-36-7 | sc-202535 sc-202535A | 1 mg 5 mg | $186.00 $674.00 | 10 | |
Chetomin disrupts HIF-1α/p300 interaction, which could indirectly influence ARNT2 activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine, a broad-spectrum kinase inhibitor, might indirectly affect ARNT2 through multiple signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, can influence various signaling pathways, potentially impacting ARNT2 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor, which might indirectly affect ARNT2 through its role in cell signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, can modulate several cellular processes, potentially influencing ARNT2 activity. | ||||||